For What Reason, PDS Biotechnology Corporation (PDSB) Stock Climbed 8.04% In Pre-market Trading.

XRX Stock

PDS Biotechnology Corporation (PDSB), a clinical-stage biotechnological company specializing to develop unique cancer therapies centered on the PDSB proprietary Versamune T-cell activating technology, announced the publication of abstract #2501 by the American Society of Clinical Oncology (ASCO). PDSB stock price surged adjacent to the news. Get the hottest stocks to trade every day before the […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.